Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.
Clinical trial NCT03606369 · UNKNOWN
Trial details
- NCT number
- NCT03606369
- Sponsor
- Instituto Nacional de Cancerologia de Mexico
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-05
- Primary completion
- 2018-07-01
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.